Skip to content
Search

Latest Stories

3 in 10 eligible women do not take up NHS cervical screening invitations

3 in 10 eligible women do not take up NHS cervical screening invitations

Less number of women attended screening in 2022-23, compared to the previous year

NHS England has urged women to accept cervical screening invites to make it possible to eliminate the disease within the next two decades.


Screening using a highly effective test helps detect human papillomavirus (HPV), which is responsible for over 99 per cent of all cervical cancers.

Sadly, three in ten of those eligible for screening do not take up the potentially life-saving offer, as shown by the NHS Cervical Screening Programme, England 2022-2023 annual report.

The report, published by NHSE on Thursday, showed that a total of 4.62 million women aged 25 to 64 for cervical screening was invited to book an appointment in 2022-23, and 3.43 million attended the screening.

Less number of women attended screening in 2022-23 (68.7 per cent), compared to the previous year (69.9 per cent).

The proportion was higher for 50- to 64-year-olds at 74.4 per cent, compared to 65.8 per cent per cent for 25- to 49-year-olds.

Steve Russell, Chief Delivery Officer and National Director for Vaccinations and Screening for NHS England, said that elimination of cervical cancer in 2040 is possible, but it relies on “millions of people continuing to come forward for screening and vaccinations every year.”

Dr Kiren Collison, a GP and NHS England’s Deputy Medical Director for Primary Care reminded women that getting the HPV vaccination and attending screening is “the best way of preventing cervical cancer”, and so they must book an appointment when invited.

If you have previously received an invitation but couldn’t attend at the time, you don’t have to wait to get another invitation.

“You can still book a cervical screening appointment even if you were invited weeks, months or years ago,” said Dr Kiren.

Last week the NHS pledged to eliminate cervical cancer by 2040 by making HPV vaccination easily accessible to people and increasing cervical screening uptake.

Women are invited for screening every three to five years depending on their age, or more frequently if HPV is detected.

Those who have been vaccinated against HPV should also attend cervical screening appointments as “the vaccine does not provide protection from all types of HPV,” the NHS noted.

The NHS cervical screening programme saves thousands of lives every year, noted Nicola Smith, Senior Health Information Manager at Cancer Research UK, as he encouraged “women and people with a cervix, such as trans men and non-binary people assigned female at birth” to take part.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less